skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: data de publicação: 1992Até2008 remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers
Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers

Batrakova, Elena V. ; Kabanov, Alexander V.

Journal of controlled release, 2008-09, Vol.130 (2), p.98-106 [Periódico revisado por pares]

Amsterdam: Elsevier B.V

Texto completo disponível

Citações Citado por
2
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

VAN CUTSEM, Eric ; MOISEYENKO, Vladimir M ; RISSE, Marie-Laure ; AJANI, Jaffer A ; TJULANDIN, Sergei ; MAJLIS, Alejandro ; CONSTENLA, Manuel ; BONI, Corrado ; RODRIGUES, Adriano ; FODOR, Miguel ; CHAO, Yee ; VOZNYI, Edouard

Journal of clinical oncology, 2006-11, Vol.24 (31), p.4991-4997 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
3
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

SALTZ, Leonard B ; CLARKE, Stephen ; COUTURE, Felix ; SIRZEN, Florin ; CASSIDY, Jim ; DIAZ-RUBIO, Eduardo ; SCHEITHAUER, Werner ; FIGER, Arie ; WONG, Ralph ; KOSKI, Sheryl ; LICHINITSER, Mikhail ; YANG, Tsai-Shen ; RIVERA, Fernando

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2013-2019 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

CASSIDY, Jim ; CLARKE, Stephen ; COUTURE, Felix ; SIRZEN, Florin ; SALTZ, Leonard ; DIAZ-RUBIO, Eduardo ; SCHEITHAUER, Werner ; FIGER, Arie ; WONG, Ralph ; KOSKI, Sheryl ; LICHINITSER, Mikhail ; YANG, Tsai-Shen ; RIVERA, Fernando

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2006-2012 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia

SHAH, Neil P ; KANTARJIAN, Hagop M ; KHOROSHKO, Nina ; PAQUETTE, Ronald L ; DEININGER, Michael ; COLLINS, Robert H ; OTERO, Irma ; HUGHES, Timothy ; BLEICKARDT, Eric ; STRAUSS, Lewis ; FRANCIS, Stephen ; HOCHHAUS, Andreas ; KIM, Dong-Wook ; REA, Delphine ; DORLHIAC-LLACER, Pedro E ; MILONE, Jorge H ; VELA-OJEDA, Jorge ; SILVER, Richard T ; KHOURY, H. Jean ; CHARBONNIER, Aude

Journal of clinical oncology, 2008-07, Vol.26 (19), p.3204-3212 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression

Orlowski, Robert Z ; Nagler, Arnon ; Sonneveld, Pieter ; Bladé, Joan ; Hajek, Roman ; Spencer, Andrew ; San Miguel, Jesús ; Robak, Tadeusz ; Dmoszynska, Anna ; Horvath, Noemi ; Spicka, Ivan ; Sutherland, Heather J ; Suvorov, Alexander N ; Zhuang, Sen H ; Parekh, Trilok ; Xiu, Liang ; Yuan, Zhilong ; Rackoff, Wayne ; Harousseau, Jean-Luc

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3892-3901 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
7
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

Cameron, David ; Casey, Michelle ; Press, Michael ; Lindquist, Deborah ; Pienkowski, Tadeusz ; Romieu, C. Gilles ; Chan, Stephen ; Jagiello-Gruszfeld, Agnieszka ; Kaufman, Bella ; Crown, John ; Chan, Arlene ; Campone, Mario ; Viens, Patrice ; Davidson, Neville ; Gorbounova, Vera ; Raats, Johannes Isaac ; Skarlos, Dimosthenis ; Newstat, Beth ; Roychowdhury, Debasish ; Paoletti, Paolo ; Oliva, Cristina ; Rubin, Stephen ; Stein, Steven ; Geyer, Charles E.

Breast cancer research and treatment, 2008-12, Vol.112 (3), p.533-543 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
8
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

GRADISHAR, William J ; TJULANDIN, Sergei ; DAVIDSON, Neville ; SHAW, Heather ; DESAI, Neil ; BHAR, Paul ; HAWKINS, Michael ; O'SHAUGHNESSY, Joyce

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7794-7803 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
9
Flux and age of dissolved organic carbon exported to the Arctic Ocean: A carbon isotopic study of the five largest arctic rivers
Flux and age of dissolved organic carbon exported to the Arctic Ocean: A carbon isotopic study of the five largest arctic rivers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Flux and age of dissolved organic carbon exported to the Arctic Ocean: A carbon isotopic study of the five largest arctic rivers

Raymond, Peter A. ; McClelland, J. W. ; Holmes, R. M. ; Zhulidov, A. V. ; Mull, K. ; Peterson, B. J. ; Striegl, R. G. ; Aiken, G. R. ; Gurtovaya, T. Y.

Global biogeochemical cycles, 2007-12, Vol.21 (4), p.GB4011-n/a [Periódico revisado por pares]

Washington, DC: American Geophysical Union

Texto completo disponível

Citações Citado por
10
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

PLUZANSKA, Anna ; SZCZESNA, Aleksandra ; JANASKOVA, Terezie ; VANSTEENKISTE, Johan ; STRAUSZ, Janos ; MOISEEVICH MANIKHAS, Georgy ; VON PAWEL, Joachim ; KAUKEL, Eckhard ; ROUBEC, Jaromir ; DE ROSA, Flavio ; MILANOWSKI, Janusz ; KARNICKA-MLODKOWSKI, Hanna ; PESEK, Milos ; SERWATOWSKI, Piotr ; RAMLAU, Rodryg

Journal of clinical oncology, 2007-04, Vol.25 (12), p.1545-1552 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (5.038)
  2. Revistas revisadas por pares (15.148)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (16.736)
  2. Anais de Congresso  (77)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1994  (5.497)
  2. 1994Até1996  (1.018)
  3. 1997Até1999  (1.466)
  4. 2000Até2003  (2.543)
  5. Após 2003  (6.293)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (5.149)
  2. Japonês  (624)
  3. Serbian  (21)
  4. Francês  (16)
  5. Ucraniano  (8)
  6. Espanhol  (4)
  7. Alemão  (1)
  8. Letão  (1)
  9. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.